Showing results (591-600 of 1,278) with videos related to
Sort By:
Pageof 128
Cancer Medicine|August 16, 2015
ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancerDonghui Li, Mayurika N Pise, Michael J Overman, et al.Cells|January 21, 2022
Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of GlioblastomaMichele Persico, Claudia Abbruzzese, Silvia Matteoni, et al.Journal of Proteome Research|June 15, 2005
Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discoveryJohn M Koomen, Donghui Li, Lian-chun Xiao, et al.The Journal of Allergy and Clinical Immunology|June 9, 1999
Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytesS E Burastero, Z Magnani, C Confetti, et al.The American Journal of Medicine|April 1, 1983
Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infectionsJ L Abbruzzese, L E Rocco, O L Laskin, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 1, 1994
Regurgitant flow of mitral valve prostheses: an intraoperative transesophageal echocardiographic studyL Meloni, G Aru, P A Abbruzzese, et al.Molecular Genetics & Genomic Medicine|September 26, 2017
1993-2014: two decades of predictive testing for Huntington's disease at the Medical Genetics Unit of the University of GenoaPaola Mandich, Merit Lamp, Fabio Gotta, et al.Oncogene|November 26, 2008
Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cellsX Sui, S Shin, R Zhang, et al.Cancer|August 30, 2008
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancerHenry Q Xiong, Gauri R Varadhachary, Joan C Blais, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2007
Long-term assessment of the risk of spread in primary late-onset focal dystoniaG Abbruzzese, A Berardelli, P Girlanda, et al.Pageof 128